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Enhanced paracellular barrier function of rat mesothelial cells partially
protects against cancer cell penetration
H Tobiokal 2, N Sawadal, Y Zhong' and M Mori'
'Department ofPathology, Sapporo Medical University School ofMedicine and the 2Department of Clinical Pathology, Sapporo
Medical University Hospital, S.1. W.17, Chuo-ku, Sapporo 060, Japan.
Summary To study pathophysiological roles of mesothelial barrier functions in protection against cancer cell
invasion, we isolated mesothelial cells from the rat abdominal cavity and cultured them with 10-6M all-trans-
retinoic acid (RA) for 10 days. Mesothelial barrier function assessed by measuring transcellular electrical
resistance (TER) and the expression of 7H6 tightjunction-associated antigen at the cell border were induced by
the treatment (10.01+0.8 vs 6.05+0.7 Qcm2 without RA; mean+s.e.m., n=10). Then we quantified the
attachment and penetration of rat mammary cancer cells (SST-2 cells) into the mesothelial cell monolayer by
prelabelling ofthe cancer cells with fluorescent dye and by observing optical sections at different heights using a
laser confocal scanning microscope. When SST-2 cells were overlaid onto the mesothelial cell monolayer
treated with RA, the number of cancer cells found at the basal level ofthe monolayer was significantly reduced.
These results showed that enhanced mesothelial barrier function at least partially prevents the penetration of
cancer cells into mesothelial cells and suggested that 7H6 antigen serves as a reliable immunocytochemical
marker for monitoring mesothelial barrier function.
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Cancer metastasis proceeds by a series of steps, among
which the capacity of cancer cells to invade surrounding
normal tissues is of central importance in the dissemina-
tion of disease. Thus, the interaction between cancer cells
and mesothelial cells lining the cavity is crucial for
achieving the complex sequence of cancer cell dissemina-
tion into the body cavity. In the process of submesothelial
invasion of cancer cells, tight junctions of mesothelial cells
may function as a defence against the invasion of cancer
cells, because the tight junction is known to work as a
barrier to the paracellular passage of cells and substances
between epithelial or endothelial cells (Madara et al.,
1992).
However, it remains obscure whether the enhancement of
tight junctional barrier function in mesothelial cells prevents
cancer cell invasion into the submesothelial tissue. The
present study was carried out in an attempt to elucidate the
relationship between the tight junctional barrier function of
mesothelial cells and the efficacy of cancer cell penetration
across the mesothelial cell monolayer in vitro.
Tight junction permeability was determined by transcel-
lular electrical resistance (TER) through the mesothelial cell
monolayer, which reflects passive ion flow through the
paracellular pathway (Claude, 1978). In addition we used
7H6 antigen expression as an immunocytochemical parameter
for the paracellular barrier function. Immunocytochemistry
for ZO-1 (Stevenson et al., 1986), the best characterised tight
junction-associated protein, was used as proof of the
localisation of 7H6 antigen at tight junctions.
The 7H6 antigen is a 155-175 kDa tight junction-
associated protein discovered in our laboratory (Zhong et
al., 1993), which has been shown to correlate closely with the
barrier function of both epithelial cells and endothelial cells
in vitro (Zhong et al., 1994).
Retinoic acid is known to induce differentiation in many
cell systems, including cultured mesothelial cells (Kim et al.,
1987). Certain retinoids enhance cell-to-cell adhesion and gap
junctional intercellular communication (Prutkin, 1975;
Chertow et al., 1983), suggesting that retinoid treatment
induces a more distinct cellular polarity maintained by tight
junction.
In this study, we assessed whether the enhancement of
mesothelial barrier function by retinoic acid acts protectively
against the invasion by rat mammary cancer cells (SST-2
cells) into the monolayer of the mesothelial cells. The results
of the present study showed that enhanced paracellular
barrier function of peritoneal mesothelial cells reduced the
efficacy of cancer cell penetration across the mesothelial cell
monolayer.
Materials and methods
Isolation and culture ofmesothelial cells
Male Fischer rats (Charles River Japan, Kanagawa, Japan),
weighing 200-250 g were used for the study. The rats were
maintained on a basal diet (Oriental Yeast Co., Tokyo,
Japan) and in rooms with temperature and light control. The
rats were sacrificed by decapitation under light anaesthesia
with diethylether, abdominal skin was stripped and exposed
followed by disinfection by 70% ethanol. Then 30 ml of
phosphate-buffered saline (PBS) supplemented with
340 U ml-1 collagenase (Yakult, Tokyo, Japan) and
800 PU ml-1 dispase (Godo-Shusei Co., Tokyo, Japan)
warmed to 37°C was injected into the abdominal space.
Special care was taken not to damage the intestines. After
incubation for 20 min at 37°C, the abdominal wall was
incised and fluid was collected from the abdominal cavity
with plastic syringes. About 20 ml of fluid was collected from
each rat. The cells were collected by centrifugation at
500 r.p.m. for 2 min three times and resuspended in a one
to one mixture of Dulbecco's modified Eagle medium
(DMEM) and Ham's F-12 medium containing 0.05%
albumin, 10-7 M dexamethasone, 100 jpg ml-1 streptomycin
(IBL, Fujioka, Japan), 100 U ml-' penicillin (IBL),
0.25 pg ml-1 fungizone (Gibco, Grand Island, NY, USA)
and 10% fetal bovine serum (Moregate, Australia). The
viability of isolated cells, assayed by trypan blue exclusion
test, was more than 95% in all experiments. The cells (3 x 105
in 4 ml of the medium described above) were inoculated onto
two 60 mm plastic dishes (Corning, NY, USA) coated with
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type I collagen (Celtris, Santa Clara, CA, USA), and
incubated at 37'C in a 95% humidified atmosphere of 5%
carbon dioxide in air. The culture medium was changed 48 h
after inoculation and every third day thereafter. After
reaching subconfluent cell density, the cells were released by
0.05% trypsin and transferred to 60 mm plastic dishes or
Transwells. Experiments were conducted using these first-
passaged mesothelial cells.
Immunocytochemistry
Mesothelial cells cultured on coverslips coated with type I
collagen were used to examine the distribution ofcytokeratin,
vimentin, ZO-1 and 7H6 antigen. Samples on coverslips for
staining of cytokeratin and vimentin were fixed with 95%
ethanol at 4°C for 10 min. Samples for staining ZO-1 and 7H6
antigen were fixed with acetone at -20°C for 5 min. The
antibodies were diluted in PBS as follows: rabbit polyclonal
antibody to cytokeratin (Dako Japan, Tokyo, Japan), 1:100;
mouse monoclonal antibody to vimentin (V9; Dako Japan),
1:10;rabbitpolyclonalantibodytoZO-1 (ZymedLaboratories,
San Francisco, CA, USA), 1: 100; mouse monoclonal antibody
to 7H6 antigen, FITC-conjugated swine anti-rabbit immuno-
globulins or FITC-conjugated rabbit anti-mouse immunoglo-
bulins(DakoJapan), 1: 100each. Sampleswereexaminedunder
a laser confocal scanning microscope MRC-500J (Bio-Rad,
Watford, UK) fitted with 40 x objectives in connection with a
Nikon Optiphot-2 upright fluorescent microscope. Digitised
fluorescent images excited by the 25 mW multiline argon ion
laser were acquired (768 x 512 pixel frame memory), filed on an
optomagnetic disc and subsequently recorded on 35 mm film.
Scanning electron microscopy
The cells cultured on type I collagen-coated glass coverslips
at 10 days after passage were fixed by 2.5% glutaraldehyde in
a 0.1 M cacodylate buffer at pH 7.4. Following dehydration
with ethanol, the cells were subjected to critical point drying,
coated with gold-palladium, and viewed under a Hitachi HS-
430 scanning electron microscope.
Retinoic acid treatment
All-trans retinoic acid (RA; Sigma, St Louis, MO, USA)
dissolved in dimethyl sulphoxide (DMSO) was added to the
medium at 1 x 10-5, 1 x 10-6, 1 x 10' and 1 x 10'8 M (final
concentration of DMSO was less than 0.01%) on the second
day after passage and thereafter added every third day.
TER measurements
The barrier function of mesothelial cells was monitored by
measurement ofTER. Mesothelialcells in thefirst passage were
seeded onto a type I collagen-precoated Transwell filter
(6.5 mm diameter and 0.4 pm pore size; Coaster, Cambridge,
MA, USA) at a density of 5.0 x 105 cells/well. The cells were
allowed to grow in the medium and incubated in a humidified
95% air/5% carbon dioxide atmosphere at 37°C. TER was
measured with an EVOM epithelial Voltohmmeter with STX-2
electrodes (World Precision Instruments, Sarasota, FL, USA)
on a heating plate (Fine, Tokyo, Japan) adjusted to 37°C. TER
was measured daily using the same wells. Measurements were
repeated at least six times for each monolayer. The final TER
values were calculated by subtracting the mean resistance of
cell-free type I collagen-coated filters from the mean total
resistance of the monolayers plus the Transwell filter and
multiplying the difference by the surface area of the filter
(0.332 cm2 for the 6.5 mm filters). The results were expressed in
standard units ofQ) cm2.
Attachment and penetration assay of SST-2 cells
SST-2, a cell line established from a mammary cancer that
spontaneously developed in SHR rats, was kindly provided
by Dr N Takeichi, Cell Biology Division, Cancer Research
Institute, Hokkaido University School of Medicine (Hamada
et al., 1987). It was maintained in DMEM containing 10%
fetal bovine serum, 100 pg ml-' streptomycin, 100 U ml -
penicillin and 0.25 pg ml-' fungizone. Mesothelial cells were
passaged on 60 mm plastic dishes precoated with 1% gelatin
(Katayama Chemical, Osaka, Japan) and cultured to
confluent density with or without RA. On the tenth day
after the passage, RA was removed from the medium by
washing the monolayer twice in PBS. SST-2 cells labelled
with PKH26 dye (Zynaxis Cell Science, Malvern, PA, USA;
2 x 10-6 M/5 x 106 cells) for 4 min and subsequently washed
three times with DMEM. The PKH26-labelled SST-2 cells
(1 x 105 cells per dish) were seeded on the confluent
mesothelial cell monolayers and cultured in the DMEM
without RA. The number of attached SST-2 cells was
counted 12 h after seeding, whereas penetrated SST-2 cells
were counted 36 h after seeding. Before the counting, the
culture medium was removed, followed by washing with PBS,
and the cells on the culture dishes were fixed with 5%
paraformaldehyde. To visualise the cell shape and height, the
cells were counterstained with rabbit polyclonal anti-
cytokeratin antibody (Dako, Japan) and FITC-conjugated
anti-rabbit IgG (Dako, Japan). For the counting, a laser
confocal scanning microscope Bio-Rad MRC-500J fitted with
20 x objectives was used. Optical sections of each cultured
mesothelial cell monolayer were taken at heights of 1 pm and
20 pm from the bottom of the dishes. The numbers of
attached cells and penetrated cells in ten different visual fields
(29 397 pm 2 each) were counted in blind fashion and
expressed as attached cells per field and penetrated cells per
field. The dots smaller than 5 pm in diameter in each optical
section were ignored as non-specific fluorescent signals or
debris of cancer cells.
Results
Characterisation of isolatedperitoneal mesothelial cells
Immunocytochemically, 95% of the isolated cells were
positive for cytokeratin. The cultured cells reached a
confluent density on days 5-7 with a doubling time of
about 20 h and had an epithelial morphology. Immunocyto-
chemically, the cells were positive for cytokeratin (Figure la)
and vimentin (Figure 1c). On scanning electron microscopy,
numerous microvilli were seen on the surface of the cells
(Figure 2). These features of the cultured cells showed their
mesothelial nature.
Effects of RA on the barrier function ofmesothelial cells
Mesothelial cells cultured with the medium supplemented
with 1 x 10'6 M RA always showed higher TER than those
cultured with control medium. TER reached approximately
165% of the control value at 10 days of treatment (Figure 3).
On the other hand, 1 x 10-7 and 1 x 10-8 M RA did not
significantly increase TER. A RA concentration of 1 x 10-5 M
was somewhat cytotoxic and the monolayer on the Transwell
filter detached within a few days.
Effects of RA on the cell shape and expression of tight
junction-associated proteins at the cell border
When cultured in medium supplemented with 1 x 10-6 M RA,
mesothelial cells retained their epithelioid morphology. There
were no significant changes in cell sheet thickness, in cell
number and in the intracyctoplasmic distribution of
cytokeratin (Figure lb) and vimentin (Figure ld) caused by
treatment of cells with 1 x 10-6 M RA. Regardless of RA
treatment, the mesothelial cells at a confluent density
expressed ZO-l at the cell border at a height of about
2 pm from the bottom of the cells (Figure 4a). On the other
hand, 7H6 antigen was shown as vesicular staining within the
cytoplasm and weak dots at the cell border (Figure 4c). UntilMesothelial barrier function and cancer cell penetration
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Figure 1 Laser confocal scanning microscopy of cultured cells showing immunocytochemistry for cytokeratin (a and b) and
vimentin (c and d). Cells cultured without RA (a and c), and with 1 x 10-6M RA for 10 days (b and d). Images were obtained at
1 grm above the coverslip surface. Bar, 20gm.
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Figure 3 Effects of RA at 1 x 10-5 (A), 1 X 10-6 (A), 1 X 10-7
([L), 1 X 10-8M (@), and control medium (0) on TER across
mesothelial cell monolayers. Data represent mean+s.e.m. of ten
individual monolayers for each.
Figure 2 Scanning electron microscopy of cells cultured without
RA for 10 days. Original magnification x 14300.
day 7 of culture, expression pattern of 7H6 antigen in
mesothelial cells cultured with 1 X 10-6 M RA was similar to
that with lower concentration of RA. After day 7, 7H6
antigen expression at the cell border was gradually
accentuated, however, cytoplasmic vesicular expression was
still dominant until day 10 of culture. On day 10 of culture,
the mesothelial cells treated with 1 x 10-6 M RA expressed
both ZO-1 (Figure 4b) and 7H6 antigen (Figure 4d) with
similar intensities at the cell border and maintained this
expression pattern until day 14 of culture.
Attachment and penetration of SST-2 cells into mesothelial
cells
Under a phase-contrast microscope, SST-2 cells seeded onto
the mesothelial cell monolayer could hardly be distinguished
from mesothelial cells (Figure 5a). PKH26 labelling made it
possible to identify the SST-2 cells by fluorescent microscopy
(Figure 5b) and the level of invading SST-2 cells in the
mesothelial monolayer was known by cytokeratin immunos-
taining. The combination of PKH26 labelling with laser
confocal scanning microscopy (LCSM) clearly identified SST-
2 cells interacting with the mesothelial cell monolayer at a
specific depth. Thus, the number of attached or penetrating
SST-2 cells was quanitified by LCSM (Figure 6). The
mesothelial cell monolayer was approximately 3 gm inMesothelial barrier function and cancer cell penetration
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height and the level of tight junction represented by ZO-l
was about 2 ,um in height. At 12 h after seeding, PKH26-
labelled SST-2 cells were seen only at a height of 20 jm
(Figure 7a and b), but not at 1 jgm (Figure 7c and d). There
were no significant differences in the number of SST-2 cells
found at 20 jim between the RA-pretreated and control
mesothelial cell monolayers (8.6+0.6 cells per field with
1 x 10-6 M RA vs 11.8 +0.8 cells per field without RA;
mean+s.e.m., n = 10). At 36 h after seeding, PKH26-labelled
SST-2 cells were found at 1 jm, in the basolateral space
under the level of the tight junction (Figure 8a and b). The
number of SST-2 cells found at a height of 1 jm in
mesothelial cell monolayers pretreated with 1 X 10-6 M RA
was 8.6+3.9 cells per field, whereas the number of SST-2
cells penetrating into the mesothelial cell monolayers without
RA pretreatment was 22.8+2.1 cells per field (mean+ s.e.m.,
n=10, P<0.01).
Discussion
The results of the present study showed that enhanced
paracellular barrier function was induced in mesothelial cells
by treatment with RA and that the increased mesothelial
barrier significantly reduced the number of cancer cells
penetrating the mesothelial cell monolayer.
In this study, we developed a new method that yielded
sizable numbers of viable mesothelial cells by a simple
procedure. Culture systems for mesothelial cells have been
established by a number of investigators, most of whom
used human materials such as pleural and abdominal
effusions (Singh et al., 1978; Wu et al., 1982; Harvey and
Amlot, 1983; La Rocca and Rheinwald, 1984; Niedbala et
al., 1985; Ke et al., 1989) surgically resected omentum (van
Hinsbergh et al., 1990; Pronk et al., 1993; Uchiyama et al.,
1992) or hernia sac (Donna et al., 1989) and pleural tissues
(Asplund and Heldin, 1994; Horai et al., 1992). However,
these materials are not always available and their cellular
features may vary from case to case. The isolation and
culture of mesothelial cells from rats has been performed by
enzyme digestion of dissected rat tissues, including the
parietal pleura (Thiollet et al., 1978; Bermudez et al., 1990),
mesentery (Akedo et al., 1986) and peeled liver capsule
(Faris et al., 1994). The system we developed seems to be
the simplest one, allowing a large yield of viable rat
mesothelial cells. The mesothelial nature of cells isolated
Figure 4 Laser confocal scanning microscopy of the monolayer showing immunocytochemistry for ZO-1 (a and b) and 7H6
antigen (c and d). Monolayers without RA (a and c, and with 1 x 10-6M RA for 10 days (b and d). Images were obtained at 1 gm
above the surface of coverslips. Bar, lOum.
$_by this procedure was confirmed by immunocytochemically
positive cytokeratin and vimentin with a characteristic
surface structure observed by scanning electron micro-
Figure 5 Phase contrast (a) and fluorescent (b) microscopy of
PKH26-labelled SST-2 cells at 36h after seeding onto the
mesothelial cell monolayer without RA treatment. Original
magnification x 100.
Mesothelial barrier function and cancer cell penetration
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scopy. They were almost free from contamination by
macrophages, fibroblasts, endothelial cells, muscle and fat
cells, blood cells and liver epithelial cells.
We examined whether the treatment enhanced mesothelial
barrier function, using TER and expression of 7H6 antigen,
which preferentially localises at the tight junction (Zhong et
al., 1993) as parameters. TER across a mesothelial monolayer
grown on type I collagen-precoated Transwell filter at a
confluent density without RA was low. The cells expressed
ZO-l but only weak 7H6 antigen at the cell border. On the
other hand, when the mesothelial cells were treated with
1 x 10-6 M RA for 10 days, they expressed 7H6 antigen
intensely at the cell border at the place where ZO-1 was
localised. TER across the monolayer with enhanced
expression of 7H6 antigen at the cell border was significantly
higher than that across the monolayer expressing less 7H6
antigen.
The mechanisms by which RA enhanced the paracellular
barrier function of mesothelial cells remain to be clarified,
but may be related to the induction of differentiation in
mesothelial cells by RA. RA is known to induce differentia-
tion in many cell systems, including cultured mesothelial cells
(Kim et al., 1987).
Using RA-treated rat mesothelial cells, we then examined
whether the enhanced mesothelial barrier function acted to
SST-2 cell
20gm
M1esothelial cell
1gm ---
- Tight junction
Figure 6 Schematic presentations of optical sectioning of the
mesothelial cell monolayer showing the process of SST-2 cell
penetration.
Figure 7 Confocal images of SST-2 cells at 20gim (a and b), and 1gim (c and d) above the surface of plastic dishes at 12h after
seeding onto the mesothelial cell monolayers without (a and c), with 1 x 10-6M RA for 10 days (b and d). Bar, 50pm.Mesothelial barrier function and cancer cell penetration
H Tobioka et al
444
Figure 8 Confocal images of SST-2 cells at 1gzm above the surface of plastic dishes at 36h after seeding onto mesothelial cell
monolayers without (a), and with 1 x 10-6M RA for 10 days (b). Bar, 50pm.
inhibit the penetration of SST-2 cancer cells into the
mesothelial cell monolayer. SST-2 cells were derived from
rat mammary cancer with high metastatic activity to the lung
when injected into the circulation (Hamada et al., 1987). SST-
2 cells are known to actively penetrate into the rat
mesothelial cell monolayer mainly through the intercellular
spaces (Li et al., 1993). We seeded PKH26-labelled SST-2
cells onto mesothelial cell monolayers and quantified their
attachment to and penetration into the mesothelial cell
monolayer by LCSM.
Although a considerable number of studies are available
for the measurement of invasive abilities of tumour cells in
vitro and in vivo (Hart and Fidler, 1978; Liotta et al., 1980;
Albini et al., 1987), the method used in this study has a
certain advantage in quantitation of penetrating cancer cells
owing to the combination of flourescent dye labelling of
cancer cells and optical sectioning of the monolayer by
LCSM. The number of SST-2 cells penetrating the
mesothelial cell monolayer 36 h after seeding was signifi-
cantly decreased by treatment of the mesothelial cell
monolayer with 1 X 10-6 M RA. The inhibition of cancer
cell invasion reciprocally correlated with the increase in the
paracellular barrier function of the mesothelial cell mono-
layer in terms of increased TER. RA treatment of the
mesothelial cell monolayer did not change the attachment of
SST-2 cells to the mesothelial cell surface. Therefore, it was
strongly suggested that enhancement of the tight junctional
barrier function of mesothelial cells partially inhibited the
penetration of cancer cells into mesothelial cell monolayers.
How cancer cells interact with mesothelial cells and pass
through the mesothelial barrier remains to be elucidated.
Akedo et al. reported that the interactions of cancer cells
with macrophages (Mukai et al., 1987), platelets (Akedo et
al., 1989), transforming growth factor-# (Mukai et al., 1989),
active oxygens (Shinkai et al., 1986), doxorubicin (Imamura
et al., 1990), serum (Imamura et al., 1991), lysophosphatidic
acid (Imamura et al., 1993), an unknown factor from rat and
bovine livers (invasion inhibiting peptide-2) (Shinkai et al.,
1988; Isoai et al., 1990; Isoai et al., 1992) and transmethyla-
tion inhibitors (Shinkai et al., 1989) modify the capacity of
cancer cells to invade mesothelial cell monolayers, but the
factors influencing the mesothelial barrier are not well
studied. It is generally agreed that transmesothelial penetra-
tion by cancer cells occurs at the junctional region between
adjacent cells. It has been reported that cancer cells induce
morphological changes of mesothelial cells by releasing some
unknown substances (Kimura et al., 1985; Uchiyama et al.,
1992) and may damage the mesothelial cells by attachment
onto the mesothelial surface (Kiyasu et al., 1981). In cultured
endothelial cells, several substances, including thrombin
(Laposata et al., 1983), active oxygen (Shasby et al., 1985),
12(S)-HETE (Tang et al., 1993), tumour necrosis factor,
interferon-y, interleukin 1 (Molony and Armstrong, 1991),
histamine (Carson et al., 1989) and tyrosine phosphatase
inhibitor (Staddon et al., 1995), are confirmed to increase
permeability. We did not find any noticeable signs of
mesothelial cell damage by cancer cells in this study, but
found that the medium conditioned by SST-2 cells rapidly
and reversibly reduced TER across the mesothelial monolayer
and caused the disappearance of 7H6 antigen from the cell
border (data not shown). From these preliminary data we
assume that unknown substances secreted by attached SST-2
cells may locally and transiently reduce the barrier function
of mesothelial cells. Identification of such substances is
necessary to understand the regulatory mechanisms of
mesothelial barrier function and to inhibit cancer cell
penetration into the mesothelium.
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